The Potential Effect of the IDH1 Mutation and MGMT Gene Promoter Methylation on the Control of Glioblastoma-Associated Epilepsy in Patients Receiving Anti-Epileptic Agents and Chemotherapies

The Potential Effect of the IDH1 Mutation and MGMT Gene Promoter Methylation on the Control of Glioblastoma-Associated Epilepsy in Patients Receiving Anti-Epileptic Agents and Chemotherapies

Objectives:(a) The objective of the study was to assess the control of seizure in glioblastoma patients receiving anti-epileptic drugs and chemotherapies after total resection and its association with O-methylguanine-DNA methyltransferase (MGMT) promoter methylation and the isocitrate dehydrogenase...

Full description

Bibliographic Details
Main Authors: Maher KURDI, Nadeem Shafique BUTT, Saleh BAEESA, Badrah ALGHAMDI, Yazid MAGHRABI, Anas BARDEESI, Rothaina SAEEDI, Fahad ALGHAMDI, Najla ALGHANMI, Mohammed BARI, Alaa SAMKARI, Ahmed LARY, Taghreed ALSINANI, Sahar HAKAMY
Format: Article
Language:English
Published: Galenos Yayinevi 2021-09-01
Series:Archives of Epilepsy
Subjects:
anti-epileptic drugs
epilepsy
glioblastoma
idh1 mutation
mgmt promotor methylation
temozolomide
Online Access: http://archepilepsy.org/archives/archive-detail/article-preview/the-potential-effect-of-the-dh1-mutation-and-mgmt-/54631

Internet

http://archepilepsy.org/archives/archive-detail/article-preview/the-potential-effect-of-the-dh1-mutation-and-mgmt-/54631

Similar Items